Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Milton, Larrondo L"'
Autor:
Claudio Pérez N, Gisselle Escobar A, Pablo Soto B, Camila Ibarra C, Milton Larrondo L, Jorge Alfaro L
Publikováno v:
Revista Hospital Clínico Universidad de Chile. 32:4-16
Platelet rich plasma (PRP) is used to speed up tissue repair. Despite its widespread use, the therapeutic application of PRP generates controversies in clinical results due to the variability in methods of obtaining the different preparations and dif
Autor:
Claudio Pérez N., Liliam León V., Araceli Pinto L., Gabriela Muñoz G., Jorge Alfaro L., Milton Larrondo L.
Publikováno v:
Revista Hospital Clínico Universidad de Chile. 30:207-17
V617F mutation in exon 14 of Janus Kinase 2 gene (jak-2) is used as a molecular marker for the diagnosis of Philadelphia negative myeloproliferative neoplasms (Phi-) such as Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibr
Publikováno v:
Revista médica de Chile v.140 n.5 2012
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Minor histocompatibility antigens (mHAgs) play a critical role in the immune responses associated with allogeneic stem cell transplantation, such as graft versus host disease (GVHD) and graft-versus-tumor (GVT). Aim: To determine the gene
Publikováno v:
Revista medica de Chile. 140(5)
Minor histocompatibility antigens (mHAgs) play a critical role in the immune responses associated with allogeneic stem cell transplantation, such as graft versus host disease (GVHD) and graft-versus-tumor (GVT).To determine the gene frequencies of th
Autor:
Alberto, Fica C, M Irene, Jemenao P, Gloria, Ruiz R, Milton, Larrondo L, Carmen, Hurtado H, Gabriela, Muñoz G, Cecilia, Sepulveda C
Publikováno v:
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 27(1)
Undergraduate healthcare students are exposed to bloodborne pathogens, and data from developing countries is scarce. We report the experience of a comprehensive program dedicated to the management of this risk. The program includes financial coverage
Autor:
Alberto Fica C, M. Irene Jemenao P, Gloria Ruiz R, Milton Larrondo L, Carmen Hurtado H, Gabriela Muñoz G, Cecilia Sepulveda C
Publikováno v:
Revista chilena de infectología v.27 n.1 2010
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Los estudiantes de pregrado de las carreras de la salud están expuestos a riesgos biológicos con agentes de transmisión sanguínea. En este trabajo se reporta la experiencia acumulada con un programa integral para este tipo de accidentes y que inc
Autor:
Luis, Alvarez L, Mauricio, Venegas S, Milton, Larrondo L, Natalia, Becerra B, Ariel, Castro L, Rodrigo, Quera P
Publikováno v:
Revista medica de Chile. 137(2)
Thiopurine S-methyltransferase (TPMT) is a cytosolic enzyme that catalyzes the S-methylation of 6-mercaptopurine and azathioprine. Low-activity phenotypes are correlated with polymorphism in the TPMT gene. Patients with low or undetectable TMPT activ
Autor:
Mauricio Venegas S, Milton Larrondo L, Ariel Castro L, Luis Álvarez L., Natalia Becerra B, Rodrigo Quera P
Publikováno v:
Revista médica de Chile v.137 n.2 2009
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Thiopurine S-methyltransferase (TPMT) is a cytosolic enzyme that catalyzes the S-methylation of 6-mercaptopurine and azathioprine. Low-activity phenotypes are correlated with polymorphism in the TPMT gene. Patients with low or undetectabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca93f00d7c2b7bb93fd1ebc5cb49a2ce
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009000200001
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009000200001
Autor:
Paola Aravena R, Néstor González G, Guillermo Conte L, Daniel Araos H, Claudio Flores P, Patricia Fardella B, Jorge Alfaro L, Milton Larrondo L
Publikováno v:
Revista médica de Chile v.133 n.8 2005
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Multiple myeloma is rarely curable. Advances in high dose chemotherapy and stem cell transplantation have improved overall survival and event-free disease periods, but relapses are inevitable. Aim: To report our experience with AT in mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306644988b6d00e54796c4e733ea9344
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800004
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800004
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.